Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China announces ban on technologies using bovine/ovine tissue:

This article was originally published in Clinica

Executive Summary

China has announced that companies must withdraw, before December 31 2006, devices and IVD reagents containing materials from bovine or ovine sources that have direct or indirect contact with the human body. The move is to prevent the spread of bovine spongiform encephalopathy (BSE). The registration certificate of products from countries where BSE is newly found will automatically become invalid and the product cannot be marketed in China. This announcement replaces the one issued on March 22 2002.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel